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background:  Genetic variants in ADAMTS7 have previously been associated with coronary calcification and the angiographic extent of coronary 
disease. Variants in a nearby gene encoding the nicotinic alpha-5 cholinergic receptor, CHRNA5, have been associated with increased smoking 
dependence, more extensive peripheral vascular disease, and lung cancer. We sought to investigate the association of regional CHRNA5-ADAMTS7 
haplotypes with mortality in patients following myocardial infarction (MI).
methods:  Caucasian subjects (N=2054) hospitalized with MI enrolled in the prospective multi-center TRIUMPH study were genotyped for 
polymorphisms in CHRNA5 and ADAMTS7. After adjusting for sex, GRACE score, and smoking status, stratified proportional hazards models were used 
to estimate independent contribution of haplotype and 1- year mortality.
results:  Seven CHRNA5-ADAMTS7 haplotypes represented 98.6% of the regional haplotypes. Although individual variants forming the haplotype 
had an association with mortality (unadjusted p values 0.04 to 2E-04), one CHRNA5-ADAMTS7 haplotype, present in 21.3% of the population, was 
significantly and strongly associated with decreased mortality at one year (p = 8E-05). After adjusting for sex, GRACE score, and smoking status, 
carriers of this haplotype had significantly decreased mortality compared to non-carriers (adjusted HR = 0.42, 95% CI 0.26, 0.68; p = 4.1E-04). 
This association remained significant at two-year follow-up (adjusted HR = 0.55, 95% CI 0.39, 0.78; p = 9.4E-04). None of the other 6 regional 
haplotypes was significantly associated with 1- or 2-year mortality.
Conclusion:  To our knowledge, this is the first description of a common CHRNA5-ADAMTS7 haplotype that is strongly associated with improved 
mortality after MI. This novel observation suggests that attention to the full regional haplotype for CHRNA5-ADAMTS7 is important for risk prediction 
and underscores the need for further research into the mechanisms by which these genetic markers confer increased risk of mortality following MI.
